Scott Sims

Scott Sims is expected to serve as Chief Commercial Officer, Sterile Injectables of Par Health. In this role, he will lead commercial strategy and execution across the company’s sterile injectables portfolio, with a focus on growth, performance, and strategic alignment.

Mr. Sims has over 30 years of pharmaceutical leadership experience in commercial operations, strategic marketing, and business development. Most recently, he served as Senior Vice President & General Manager at Endo, Inc. and its predecessor Endo International plc, overseeing its injectable and generics businesses. His earlier roles include senior positions at Endo, Par Pharmaceutical, Bedford Laboratories, Fleming Pharmaceuticals, and Mallinckrodt Pharmaceuticals, where he built commercial infrastructure, launched products, and drove growth across branded and generic injectable portfolios.

He studied International Business at Seton Hall University, holds a Bachelor of Science in Marketing from Southern Illinois University, and has completed executive programs at Northwestern University’s Kellogg School of Management.